These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12952752)

  • 1. A review of thalidomide's history and current dermatological applications.
    Perri AJ; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative uses of thalidomide.
    Chen M; Doherty SD; Hsu S
    Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
    J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
    J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
    Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide: a re-look.
    Grover JK; Vats V; Gopalakrishna R; Ramam M
    Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide and its dermatologic uses.
    Moraes M; Russo G
    Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Should thalidomide be rehabilitated?].
    Belaube P; Garcin G; Marchand JP; Privat Y
    Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide and its impact in dermatology.
    Stirling DI
    Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL; Valente Mdo S
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide: new preparation. For well-defined indications.
    Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

  • 20. A case series of 48 patients treated with thalidomide.
    Doherty SD; Hsu S
    J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.